Vasilios Panagiotakopoulos - Beleave COO, CEO
Insider
Vasilios Panagiotakopoulos is COO, CEO of Beleave
| Age | 47 |
| Phone | 844-235-3283 |
| Web | https://beleave.com |
Beleave Management Efficiency
The company has return on total asset (ROA) of (0.2501) % which means that it has lost $0.2501 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (1.275) %, meaning that it generated substantial loss on money invested by shareholders. Beleave's management efficiency ratios could be used to measure how well Beleave manages its routine affairs as well as how well it operates its assets and liabilities.Similar Executives
| Found 13 records | INSIDER Age | ||
| Kevin Pitts | Grey Cloak Tech | 63 | |
| Thomas Flow | Akanda Corp | 46 | |
| Chad White | Sonoma Pharmaceuticals | 51 | |
| BComm BCom | Akanda Corp | 68 | |
| Lin Yang | Universe Pharmaceuticals | 48 | |
| Gang Lai | Universe Pharmaceuticals | 56 | |
| BCom BAcc | Akanda Corp | 44 | |
| Robert Madden | Grey Cloak Tech | 51 | |
| Sam Hsing | China Pharma Holdings | N/A | |
| Baochang Liu | Universe Pharmaceuticals | 44 | |
| Scott Landers | Grey Cloak Tech | N/A | |
| Tejinder Virk | Akanda Corp | 42 | |
| Victoria Covel | Sonoma Pharmaceuticals | N/A | |
Management Performance
| Return On Equity | -1.27 | |||
| Return On Asset | -0.25 |
Beleave Leadership Team
Elected by the shareholders, the Beleave's board of directors comprises two types of representatives: Beleave inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Beleave. The board's role is to monitor Beleave's management team and ensure that shareholders' interests are well served. Beleave's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Beleave's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Vasilios Panagiotakopoulos, COO, CEO | ||
| Myles Fontaine, VP Sales | ||
| Justin Kosalka, Director Operations | ||
| Keith CPA, Interim Officer | ||
| Roger Ferreira, CoFounder Officer | ||
| Lieutenant Gidlow, Head Outreach |
Beleave Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right pink sheet is not an easy task. Is Beleave a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -1.27 | |||
| Return On Asset | -0.25 | |||
| Operating Margin | (3.87) % | |||
| Current Valuation | 5.66 K | |||
| Shares Outstanding | 566.37 M | |||
| Price To Earning | (4.44) X | |||
| Price To Book | 0 X | |||
| Price To Sales | 0.0002 X | |||
| Revenue | 2.37 M | |||
| Gross Profit | 816.46 K |
Currently Active Assets on Macroaxis
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in real. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .
Other Consideration for investing in Beleave Pink Sheet
If you are still planning to invest in Beleave check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Beleave's history and understand the potential risks before investing.
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Idea Analyzer Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |